Abstract
Research in our laboratory has focused on new methods for improving the therapeutic efficacy of anthracyclines by overcoming host toxicities and increasing their action against sensitive and resistant tumor types. We now summarize our findings from two novel methods of drug delivery. The first approach utilized liposome-concealed Adriamycin (ADR), which delivers the drug by mechanisms other than those normally used. The second method provides multiple drug-binding sites by covalently coupling ADR to a polymer support.
Author to whom correspondence should be directed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Forssen EA, Tokes ZA. 1979. In vitro and in vivo studies with adriamycin liposomes. Biochem. Biophys. Res. Commun. 91: 1295–1301.
Forssen EA, Tokes ZA. 1981. Use of anionic liposomes for the reduction 0: chronic doxorubicin induced cardiotoxicity. 1981. Proc. Nat. Acad. Sci. USA 78: 1873–1877.
Enoch HG, Strittmatter P. 1979. Formation and properties of 1000 Ä diameter, single bilayer phospholipid vesicles. Proc. Nat. Acad. Sci. USA 76: 145–149.
Margel S, Zisblatt S, Rembaum A. 1979. Polyglutaraldehyde: A new reagent for coupling proteins to microspheres and for labeling cell-surface receptors. II. Simplified labeling method by means of non-magnetic and magnetic polyglutaraldehyde microspheres. J. Immunol. Methods 28: 341–353.
Casazza AM. 1979. Experimental evaluation of anthracycline analogs. Cancer Treat. Rep. 63: 835–844.
Carter SK. 1980. Clinical evaluation of analogs. III. Anthracyclines. Cancer Chemother. Phannacol. 4: 5–10.
Vecchi A, Mantovani A, Tagliablue A, Spreafico F. 1976. A characterization of the immunosuppressive activity of adriamycin and daunomycin on hurrora1 antibody production and turror allograft rejection. Cancer Res. 36: 1222–1227.
Rahman YE, Hanson WR, Bharucha J, Ainsworth EJ, Jaroslcw BN. 1978. Mechanisms of reduction of antitumor drug toxicity by liposome encapsulation. Ann. NY Acad. Sci. 308: 325–342.
Di Marco A. 1975. Adriamycin: mode and mechanism of action. Cancer Chemother. Rep., part 3, 6: 91–106.
Nakata Y, Hopfinger AJ. 1980. Predicted mode of intercalation of doxorubicin with dinucleotide dimers. Biochem. Biophys. Res. Comm. 95: 583–588.
Goormaghtigh E, Chatelan P, Caspers J, Ruysschaert JM. 1980. Evidence of a complex between Adriamycin derivatives and cardiolipin: Possible role in cardiotoxicity. Biochem. Pharmacol. 29: 3003–3010.
Thayer WS. 1977. Adriamycin stimulated superoxide formation in submitochondrial particles. Chem. Biol. Interact. 19: 265–278.
Flickenger CO, Brown JC, Kutchai HC, Ogilvie J. 1979. Medical cell biology. Philadelphia, W. B. Saunders Co.
Condeelis J. 1979. Isolation of concanavalin A caps during various stages of formation and their association with actin and myosin. J. Cell. Biol. 80: 751–754.
Gaudio LA, Yesair OW, Taylor RF. 1980. Cancer chemotherapeutic drug binding to macromolecular lipids from L1210 leukemia cells and to known lipids. Proc. Amer. Assoc. Cancer Res. 21: 18.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Rogers, K.E., Forssen, E.A., Töklès, Z.A. (1982). Alternative Methods of Drug Delivery. In: Muggia, F.M., Young, C.W., Carter, S.K. (eds) Anthracycline Antibiotics in Cancer Therapy. Developments in Oncology, vol 10. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7630-6_25
Download citation
DOI: https://doi.org/10.1007/978-94-009-7630-6_25
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7632-0
Online ISBN: 978-94-009-7630-6
eBook Packages: Springer Book Archive